Synergistic interactions of the anti-casein kinase 2 CIGB-300 peptide and chemotherapeutic agents in lung and cervical preclinical cancer models.
about
Molecules that target nucleophosmin for cancer treatment: an updateOptimizing CIGB-300 intralesional delivery in locally advanced cervical cancer.CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.Cryptotanshinone inhibits lung tumor growth by increasing CD4+ T cell cytotoxicity through activation of the JAK2/STAT4 pathway.
P2860
Synergistic interactions of the anti-casein kinase 2 CIGB-300 peptide and chemotherapeutic agents in lung and cervical preclinical cancer models.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Synergistic interactions of th ...... cal preclinical cancer models.
@ast
Synergistic interactions of th ...... cal preclinical cancer models.
@en
Synergistic interactions of th ...... cal preclinical cancer models.
@nl
type
label
Synergistic interactions of th ...... cal preclinical cancer models.
@ast
Synergistic interactions of th ...... cal preclinical cancer models.
@en
Synergistic interactions of th ...... cal preclinical cancer models.
@nl
prefLabel
Synergistic interactions of th ...... cal preclinical cancer models.
@ast
Synergistic interactions of th ...... cal preclinical cancer models.
@en
Synergistic interactions of th ...... cal preclinical cancer models.
@nl
P2093
P2860
P356
P1476
Synergistic interactions of th ...... cal preclinical cancer models.
@en
P2093
Hernan G Farina
Jorge Fernandez-DE-Cossio
Larisa Gorovaya
Neylen Del Toro
Silvio E Perea
Yasser Perera
P2860
P304
P356
10.3892/MCO.2014.338
P577
2014-07-08T00:00:00Z